These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28902230)

  • 1. Chronic kidney disease and metabolic syndrome as risk factors for cardiovascular disease in a primary care program.
    Greffin S; André MB; Matos JPS; Kang HC; Jorge AJL; Rosa MLG; Lugon JR
    J Bras Nefrol; 2017; 39(3):246-252. PubMed ID: 28902230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
    Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of clustering of major cardiovascular risk factors with chronic kidney disease in the adult population.
    Kong X; Ma X; Cui M; Xu D
    Clin Nephrol; 2014 Aug; 82(2):92-7. PubMed ID: 24887299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome and its components are differentially associated with chronic diseases in a high-risk population of 350 000 adults: A cross-sectional study.
    Rayyan Assi H; Ziv A; Dankner R
    Diabetes Metab Res Rev; 2019 May; 35(4):e3121. PubMed ID: 30600581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk prediction in chronic kidney disease patients.
    Cedeño Mora S; Goicoechea M; Torres E; Verdalles Ú; Pérez de José A; Verde E; García de Vinuesa S; Luño J
    Nefrologia; 2017; 37(3):293-300. PubMed ID: 28495396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.
    Robles NR; Felix FJ; Fernandez-Berges D; Perez-Castán JF; Zaro MJ; Lozano L; Alvarez-Palacios P; Garcia-Trigo A; Tejero V; Morcillo Y; Hidalgo AB
    J Nephrol; 2013; 26(4):675-82. PubMed ID: 23100180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease.
    Weiner DE; Tabatabai S; Tighiouart H; Elsayed E; Bansal N; Griffith J; Salem DN; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2006 Sep; 48(3):392-401. PubMed ID: 16931212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Of heart and kidney: a complicated love story.
    Gaita D; Mihaescu A; Schiller A
    Eur J Prev Cardiol; 2014 Jul; 21(7):840-6. PubMed ID: 23012690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between chronic kidney disease and cardiovascular disease risk factors in atomic bomb survivors.
    Sera N; Hida A; Imaizumi M; Nakashima E; Akahoshi M
    Radiat Res; 2013 Jan; 179(1):46-52. PubMed ID: 23148507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of erectile dysfunction in Spanish primary care setting and its association with cardiovascular risk factors and cardiovascular diseases. SIMETAP-ED study.
    Ruiz-García A; Arranz-Martínez E; Cabrera-Vélez R; Palacios-Martínez D; Rivera-Teijido M; García-Álvarez JC; Morales-Cobos LE; Moreno-Fernández JC; García-Fernández ME; Peña-Antón N; Díez-Pérez MC; Montero-Costa A; Lorenzo-Borda MS; García-Granado MD; Casaseca-Calvo TF; Cique-Herráinz JA; García-Villasur MP; Marañón-Henrich N; Zarzuelo-Martín N; Baltuille-Aller MC; Arribas-Álvaro P; Macho-Barrio AI; Ribot-Catalá C; Capitán-Caldas M; Ciria-de-Pablo C; Sanz-Velasco C; Vargas-Machuca-Cabañero C; Simonaggio-Stancampiano P; Cabello-Igual MP; Sarria-Sánchez MT; ;
    Clin Investig Arterioscler; 2019; 31(3):101-110. PubMed ID: 30979438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between metabolic syndrome and chronic kidney disease in a Chinese urban population.
    Chen J; Kong X; Jia X; Li W; Wang Z; Cui M; Xu D
    Clin Chim Acta; 2017 Jul; 470():103-108. PubMed ID: 28501388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    Nephron Clin Pract; 2012; 122(1-2):58-65. PubMed ID: 23548499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Kidney Disease and Lipid Disorders.
    Zubovic SV; Kristic S; Prevljak S; Pasic IS
    Med Arch; 2016 Jun; 70(3):191-2. PubMed ID: 27594744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity related risk for chronic kidney disease progression and cardiovascular disease after propensity score matching.
    Barbieri D; Goicoechea M; García-Prieto A; Delgado A; Verde E; Verdalles U; Pérez de José A; Carbayo J; Muñoz de Morales A; Luño J
    Hipertens Riesgo Vasc; 2021; 38(2):63-71. PubMed ID: 33759767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the MDRD Study and the CKD-EPI Study equations in evaluating trends of estimated kidney function at population level: findings from the National FINRISK Study.
    Juutilainen A; Kastarinen H; Antikainen R; Peltonen M; Salomaa V; Tuomilehto J; Jousilahti P; Sundvall J; Laatikainen T; Kastarinen M
    Nephrol Dial Transplant; 2012 Aug; 27(8):3210-7. PubMed ID: 22492828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in early stages of chronic kidney disease in a Chinese population.
    Zhang L; Zuo L; Wang F; Wang M; Wang S; Lv J; Liu L; Wang H
    J Am Soc Nephrol; 2006 Sep; 17(9):2617-21. PubMed ID: 16885404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
    Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.